131 related articles for article (PubMed ID: 32557260)
1. Pre-dialysis serum creatinine as an independent predictor of responsiveness to zinc supplementation among patients on hemodialysis.
Okamoto T; Hatakeyama S; Togashi K; Hamaya T; Tanaka Y; Imanishi K; Takashima T; Saitoh F; Suzuki T; Ohyama C
Clin Exp Nephrol; 2020 Oct; 24(10):955-962. PubMed ID: 32557260
[TBL] [Abstract][Full Text] [Related]
2. Comparison of zinc acetate hydrate and polaprezinc for zinc deficiency in patients on maintenance hemodialysis: A single-center, open-label, prospective randomized study.
Okamoto T; Hatakeyama S; Konishi S; Okita K; Tanaka Y; Imanishi K; Takashima T; Saitoh F; Suzuki T; Ohyama C
Ther Apher Dial; 2020 Oct; 24(5):568-577. PubMed ID: 31794152
[TBL] [Abstract][Full Text] [Related]
3. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.
Kobayashi H; Abe M; Okada K; Tei R; Maruyama N; Kikuchi F; Higuchi T; Soma M
Nutrients; 2015 May; 7(5):3783-95. PubMed ID: 25988769
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease.
Himoto T; Hosomi N; Nakai S; Deguchi A; Kinekawa F; Matsuki M; Yachida M; Masaki T; Kurokochi K; Watanabe S; Senda S; Kuriyama S
Scand J Gastroenterol; 2007 Sep; 42(9):1078-87. PubMed ID: 17710674
[TBL] [Abstract][Full Text] [Related]
5. Effects of Zinc Acetate Hydrate Supplementation on Renal Anemia with Hypozincemia in Hemodialysis Patients.
Sato E; Sato S; Degawa M; Ono T; Lu H; Matsumura D; Nomura M; Moriyama N; Amaha M; Nakamura T
Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355996
[TBL] [Abstract][Full Text] [Related]
6. Effects of zinc supplementation on serum zinc concentration and ratio of apo/holo-activities of angiotensin converting enzyme in patients with taste impairment.
Takaoka T; Sarukura N; Ueda C; Kitamura Y; Kalubi B; Toda N; Abe K; Yamamoto S; Takeda N
Auris Nasus Larynx; 2010 Apr; 37(2):190-4. PubMed ID: 19716667
[TBL] [Abstract][Full Text] [Related]
7. Zinc Acetate Hydrate Supplementation versus Polaprezinc Supplementation for Improving Hypozincemia in Hemodialysis Patients: A Randomized Clinical Trial.
Kumagai E; Furumachi K; Kurihara A; Hosokawa K; Hosohata K; Takai S
Int J Nephrol; 2023; 2023():2403755. PubMed ID: 37840640
[TBL] [Abstract][Full Text] [Related]
8. Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients.
Fukushima T; Horike H; Fujiki S; Kitada S; Sasaki T; Kashihara N
Ther Apher Dial; 2009 Jun; 13(3):213-9. PubMed ID: 19527468
[TBL] [Abstract][Full Text] [Related]
9. Oral treatment of pressure ulcers with polaprezinc (zinc L-carnosine complex): 8-week open-label trial.
Sakae K; Yanagisawa H
Biol Trace Elem Res; 2014 Jun; 158(3):280-8. PubMed ID: 24691900
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Polaprezinc (Zinc Compound) on Zinc Deficiency: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials Using Individual Patient Data.
Furihata K; Tsuchikawa M; Miwa T; Naito Y; Oba K; Sakagami M
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316581
[TBL] [Abstract][Full Text] [Related]
11. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
Chevalier CA; Liepa G; Murphy MD; Suneson J; Vanbeber AD; Gorman MA; Cochran C
J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
[TBL] [Abstract][Full Text] [Related]
12. Effects of zinc supplementation on serum zinc and C-reactive protein concentrations in hemodialysis patients.
Rashidi AA; Salehi M; Piroozmand A; Sagheb MM
J Ren Nutr; 2009 Nov; 19(6):475-8. PubMed ID: 19541504
[TBL] [Abstract][Full Text] [Related]
13. [Involvement of zinc in taste disturbance occurring during treatment for malignant tumor in the chest and the effects of polaprezinc oral disintegrating tablets (a retrospective study)].
Nakata Y; Hirashima T; Kondou Y; Tokuoka Y; Imazato H; Iwata K; Oomori Y; Yamato A; Shimizu S; Nagao S; Matsui K; Abe N
Gan To Kagaku Ryoho; 2008 Jun; 35(6):955-9. PubMed ID: 18633224
[TBL] [Abstract][Full Text] [Related]
14. Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin.
Murakami Y; Koyabu T; Kawashima A; Kakibuchi N; Kawakami T; Takaguchi K; Kita K; Okita M
J Nutr Sci Vitaminol (Tokyo); 2007 Jun; 53(3):213-8. PubMed ID: 17874825
[TBL] [Abstract][Full Text] [Related]
15. Preparation and clinical evaluation of a novel lozenge containing polaprezinc, a zinc-L-carnosine, for prevention of oral mucositis in patients with hematological cancer who received high-dose chemotherapy.
Hayashi H; Kobayashi R; Suzuki A; Yamada Y; Ishida M; Shakui T; Kitagawa J; Hayashi H; Sugiyama T; Takeuchi H; Tsurumi H; Itoh Y
Med Oncol; 2016 Aug; 33(8):91. PubMed ID: 27418192
[TBL] [Abstract][Full Text] [Related]
16. The effects of zinc supplementation on serum zinc concentration and protein catabolic rate in hemodialysis patients.
Jern NA; VanBeber AD; Gorman MA; Weber CG; Liepa GU; Cochran CC
J Ren Nutr; 2000 Jul; 10(3):148-53. PubMed ID: 10921536
[TBL] [Abstract][Full Text] [Related]
17. Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
Murakami-Nakayama M; Tsubota M; Hiruma S; Sekiguchi F; Matsuyama K; Kimura T; Moriyama M; Kawabata A
J Pharmacol Sci; 2015 Feb; 127(2):223-8. PubMed ID: 25727961
[TBL] [Abstract][Full Text] [Related]
18. Tissue distribution of polaprezinc in rats determined by the double tracer method.
Furuta S; Suzuki M; Toyama S; Miwa M; Sano H
J Pharm Biomed Anal; 1999 Mar; 19(3-4):453-61. PubMed ID: 10704111
[TBL] [Abstract][Full Text] [Related]
19. Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C.
Takagi H; Nagamine T; Abe T; Takayama H; Sato K; Otsuka T; Kakizaki S; Hashimoto Y; Matsumoto T; Kojima A; Takezawa J; Suzuki K; Sato S; Mori M
J Viral Hepat; 2001 Sep; 8(5):367-71. PubMed ID: 11555194
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of zinc-carnosine chelate compound, Polaprezinc, enemas in patients with ulcerative colitis.
Itagaki M; Saruta M; Saijo H; Mitobe J; Arihiro S; Matsuoka M; Kato T; Ikegami M; Tajiri H
Scand J Gastroenterol; 2014 Feb; 49(2):164-72. PubMed ID: 24286534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
